HyperMed Imaging, Inc. is a privately held medical device company located in Memphis, TN. We are focused on providing innovative solutions for superficial tissue oximetry applications. Our vision is to improve the lives of patients suffering from complications of vascular disease and diabetes.
We seek to develop products that will enable better clinical outcomes for applications involving wound care, amputation, and vascular and reconstructive surgery. Limb preservation and limb salvage is a central objective in this effort.
HyperMed commercialized the first generation hyperspectral imaging device that was used in clinical research that established the benefits of the technology in comparison to other standards of care.
The company has developed a smaller, more portable product utilizing our core hyperspectral imaging technology. The new product has undergone clinical testing and is FDA 510(k) cleared.